Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma.

Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma.
复制标题

第三代EGFRVIII特异性嵌合抗原受体的脑内递送有效地针对人神经胶质瘤。

DOI:
10.1016/j.jocn.2013.03.012
复制
发表时间:
2014-01
影响因子:
2
通讯作者:
Sampson, John H.
Sampson, John H.
中科院分区:
医学4区
文献类型:
--
作者:
Choi, Bryan D.;Suryadevara, Carter M.;Gedeon, Patrick C.;Herndon, James E., II;Sanchez-Perez, Luis;Bigner, Darell D.;Sampson, John H.

文献摘要

参考文献

被引文献

相似文献

嵌合抗原受体(CAR)转导的T细胞在恶性疾病的治疗中具有很大的前景。在这里,我们证明了脑内注射人表皮生长因子受体变体III(EGFRvIII)特异性第三代CAR成功治疗小鼠胶质瘤。重要的是,这些结果支持这种CAR在表达EGFRvIII的脑肿瘤患者中的临床翻译。
Chimeric antigen receptors (CAR)-transduced T cells hold great promise in the treatment of malignant disease. Here, we demonstrate that intracerebral injection with a human, epidermal growth factor receptor variant III (EGFRvIII)-specific, third generation CAR successfully treats glioma in mice. Importantly, these results endorse clinical translation of this CAR in patients with EGFRvIII-expressing brain tumors.
DOI: 10.1111/j.1349-7006.2010.01734.x
发表时间: 2010-12-01
期刊: CANCER SCIENCE
影响因子: 5.7
作者:
Ohno, Masasuke;Natsume, Atsushi;Wakabayashi, Toshihiko
通讯作者: Wakabayashi, Toshihiko
DOI: 10.1111/j.1750-3639.2009.00318.x
发表时间: 2009-10
期刊: Brain pathology (Zurich, Switzerland)
影响因子: --
作者:
Choi BD;Archer GE;Mitchell DA;Heimberger AB;McLendon RE;Bigner DD;Sampson JH
通讯作者: Sampson JH
DOI: 10.1089/hum.2012.041
发表时间: 2012-10-01
期刊: HUMAN GENE THERAPY
影响因子: 4.2
作者:
Morgan, Richard A.;Johnson, Laura A.;Rosenberg, Steven A.
通讯作者: Rosenberg, Steven A.
DOI: 10.1007/s11060-009-9889-1
发表时间: 2009-09
影响因子: 3.9
作者:
Bullain SS;Sahin A;Szentirmai O;Sanchez C;Lin N;Baratta E;Waterman P;Weissleder R;Mulligan RC;Carter BS
通讯作者: Carter BS
DOI: 10.1016/j.jocn.2012.05.040
发表时间: 2013-05-01
影响因子: 2
作者:
Smoll, Nicolas R.;Schaller, Karl;Gautschi, Oliver P.
通讯作者: Gautschi, Oliver P.